Manipulating the Wnt/ß-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy.

Persons

Thomas C Randall

Venue / Journal

Gynecol Oncol

Date

Fri, 01/01/2021 - 12:00

Additional Journal Information

160(1):285-294

Authors

Wall JA, Meza-Perez S, Scalise CB, Katre A, Londoño AI, Turbitt WJ, Randall T, Norian LA, Arend RC.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/33168307